Home
>
National Drug Code (NDC)
>
Banzel
Banzel - 62856-583-52 - (rufinamide)
Drug Information of Banzel
| Product NDC: | 62856-583 |
| Proprietary Name: | Banzel |
| Non Proprietary Name: | rufinamide |
| Active Ingredient(s): | 400 mg/1 & nbsp; rufinamide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Banzel
| Product NDC: | 62856-583 |
| Labeler Name: | Eisai Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021911 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20081114 |
Package Information of Banzel
| Package NDC: | 62856-583-52 |
| Package Description: | 120 TABLET, FILM COATED in 1 BOTTLE (62856-583-52) |
NDC Information of Banzel
| NDC Code | 62856-583-52 |
| Proprietary Name | Banzel |
| Package Description | 120 TABLET, FILM COATED in 1 BOTTLE (62856-583-52) |
| Product NDC | 62856-583 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | rufinamide |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20081114 |
| Marketing Category Name | NDA |
| Labeler Name | Eisai Inc. |
| Substance Name | RUFINAMIDE |
| Strength Number | 400 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
